Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAM study of SAMe for depression in bipolar disorder with childhood trauma
NL-OMON21753Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of S-adenosylmethionine in bipolar disorder (BD) and major depressive disorder (MDD) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Hamilton Depression Rating Scale response. Planned start Dec 2017; status: not yet recruiting.
02
Drugs
S-adenosylmethionine
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON21753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21753.